Cargando…

(68)Ga‐Labelled Tropane Analogues for the Visualization of the Dopaminergic System

The development of radiometal‐labelled pharmaceuticals for neuroimaging could offer great potential due to easier handling during labelling and availability through radionuclide generator systems. Nonetheless, to date, no such tracers are available for positron emission tomography, primarily owing t...

Descripción completa

Detalles Bibliográficos
Autores principales: Häseli, Sascha, Holy, Marion, Joksch, Markus, Bergner, Carina, Wree, Andreas, Kurth, Jens, Cankaya, Aylin, Piel, Markus, Krause, Bernd J., Sitte, Harald H., Rösch, Frank
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7984292/
https://www.ncbi.nlm.nih.gov/pubmed/33245194
http://dx.doi.org/10.1002/cmdc.202000820
Descripción
Sumario:The development of radiometal‐labelled pharmaceuticals for neuroimaging could offer great potential due to easier handling during labelling and availability through radionuclide generator systems. Nonetheless, to date, no such tracers are available for positron emission tomography, primarily owing to the challenge of crossing the blood–brain barrier (BBB) and loss of affinity through chelator attachment. We have prepared a variety of (68)Ga‐labelled phenyltropanes showing that, through a simple hydrocarbon‐linker, it is possible to introduce a chelator onto the lead structure while maintaining its high affinity for hDAT (human dopamine transporter) and simultaneously achieving adequate lipophilicity. One of the candidates, [(68)Ga]Ga‐HBED‐hexadiyne‐tropane, showed an IC(50) value of 66 nM, together with a log D (7.4) of 0.96. A μPET study in a hemi‐parkinsonian rat model showed a fast wash‐out of the tracer, and no specific uptake in the brain, thus implying an inability to penetrate the BBB.